Back Cryptosporidium Afrikaans خفية الأبواغ Arabic كريبتوسبوريديوم ARZ Kriptosporidlər Azerbaijani Cryptosporidium Catalan Cryptosporidium Czech Kryptosporidien German Cryptospurìdium EML Cryptosporidium Spanish Cryptosporidium Basque
 | This article is missing information about effects of Cryptosporidium infection on groups of animals other than mammals. (August 2023) |
| Cryptosporidium | |
|---|---|
| |
| Oocysts of C. muris found in human feces | |
Scientific classification 
| |
| Domain: | Eukaryota |
| Clade: | Diaphoretickes |
| Clade: | SAR |
| Clade: | Alveolata |
| Phylum: | Apicomplexa |
| Class: | Conoidasida |
| Order: | Eucoccidiorida |
| Suborder: | Eimeriorina |
| Family: | Cryptosporidiidae |
| Genus: | Cryptosporidium Tyzzer, 1907 |
| Species | |
|
See § Species | |
Cryptosporidium, sometimes called crypto, is an apicomplexan genus of alveolates which are parasites that can cause a respiratory and gastrointestinal illness (cryptosporidiosis) that primarily involves watery diarrhea (intestinal cryptosporidiosis), sometimes with a persistent cough (respiratory cryptosporidiosis).[1][2]
Treatment of gastrointestinal infection in humans involves fluid rehydration, electrolyte replacement, and management of any pain. For cryptosporidiosis, supportive treatment and symptom management are the primary treatments for immunocompetent individuals.[3] Anti-diarrheal medication, such as Loperamide, may be effective in slowing the rate of diarrhea. Nitazoxanide is the only drug approved for the treatment of cryptosporidiosis in immunocompetent persons.[4] Supplemental zinc may improve symptoms,[5] particularly in recurrent or persistent infections or in others at risk for zinc deficiency. Cryptosporidium oocysts are 4–6 μm in diameter and exhibit partial acid-fast staining. They must be differentiated from other partially acid-fast organisms including Cyclospora cayetanensis.
- ^ Sponseller JK, Griffiths JK, Tzipori S (July 2014). "The evolution of respiratory Cryptosporidiosis: evidence for transmission by inhalation". Clinical Microbiology Reviews. 27 (3): 575–86. doi:10.1128/CMR.00115-13. PMC 4135895. PMID 24982322.
Recent evidence indicates that respiratory cryptosporidiosis may occur commonly in immunocompetent children with cryptosporidial diarrhea and unexplained cough. Findings from animal models, human case reports, and a few epidemiological studies suggest that Cryptosporidium may be transmitted via respiratory secretions, in addition to the more recognized fecal-oral route. ... Upper respiratory cryptosporidiosis may cause inflammation of the nasal mucosa, sinuses, larynx, and trachea, accompanied by nasal discharge and voice change (54, 61, 62). Cryptosporidiosis of the lower respiratory tract typically results in productive cough, dyspnea, fever, and hypoxemia (63,–66). ... While fecal-oral transmission is indisputably the major route of infection, transmission via coughing and fomites is also possible in situations of close contact (20). ... Because they lacked gastrointestinal symptoms and oocyst excretion, the latter cases establish the possibility of primary respiratory infection with Cryptosporidium, which may have been acquired by inhalation of expectorated droplets or by contact with fomites. ... This finding suggests that respiratory cryptosporidiosis may occur commonly in immunocompetent individuals.
- ^ Chalmers, Rachel M.; Davies, Angharad P.; Tyler, Kevin (1 May 2019). "Cryptosporidium". Microbiology. 165 (5): 500–502. doi:10.1099/mic.0.000764. ISSN 1350-0872. PMID 31268415. S2CID 243706992.
- ^ Leder, Karin. "Cryptosporidiosis: Treatment and Prevention". UpToDate. Retrieved 4 August 2023.
- ^ Love, MS; Choy, RKM (1 October 2021). "Emerging treatment options for cryptosporidiosis". Current Opinion in Infectious Diseases. 34 (5): 455–462. doi:10.1097/QCO.0000000000000761. PMC 7611666. PMID 34261904.
- ^ Cabada MM, White AC, Venugopalan P, Sureshbabu J (18 August 2015). Bronze MS (ed.). "Cryptosporidiosis Treatment & Management". Medscape. WebMD. Retrieved 8 January 2016.
Infection may improve with nutritional supplementation, particularly with regimens including zinc or glutamine. ... Nitazoxanide significantly shortens the duration of diarrhea and can decrease the risk of mortality in malnourished children.[22] Trials have also demonstrated efficacy in adults.[26, 27] ... Symptomatic therapy includes replacement of fluids, provision of appropriate nutrition, and treatment with antimotility agents. ... Replacement of fluids and electrolytes is the critically important first step in the management of cryptosporidiosis, particularly in patients with large diarrheal losses. Fluids should include sodium, potassium, bicarbonate, and glucose.
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search